Cannabis: the emerging face of well-being.
Medicinal Organic Cannabis Australia (MOCA) is fully licenced at State and Federal Government level medical cannabis company with offices in Sydney Australia and Auckland, New Zealand. The company is specialized in the import and export of organic cannabis based medication for Australian, New Zealand, and international Markets.
As wholesalers of medical cannabis products, MOCA’s clients include within the medical industry, doctors, pharmacies, and hospitals.
We import and export a range of organic and non-organic CBD and THC medications, rich in cannabidiol and tetrahydrocannabinol. The Company has licences from the State and Federal Government to import under the Regulation 5 of the Customs (Prohibited Imports) Regulations 1956.
Medicinal Organic Cannabis Australia (MOCA) has developed strategic partnerships with leading global cannabis manufacturers and producers, which offer a proven, sustainable, stream of high quality products.
We are supported by an international leading scientific team to bring the best products to Australian and global markets. Ongoing multinational best practices research informs the company’s decisions into products, markets, and cannabis cultivation methods.
Our Vision is a world where wellness abounds and where the medical healing properties of the cannabis plant become researched, understood, and integrated into medical and wellness industries worldwide.
Business Model based on Research
MOCA’s business model leverages strategic scientific research partnerships with high levels of technical and procedural knowledge in cultivating, processing, and producing medicinal organic cannabis products.
MOCA Activities at a glance
MOCA is a wholly owned Australian company that commenced operations in March 2017, incorporated in June 2017 and has its registered office at 903/50 Clarence Street, Sydney Australia.
The Company holds licences at State and Federal level to import and export Schedule 4 (CBD) and Schedule 8 (THC and CBD) products and wholesale to the medical industry.
MOCA is the first Australian company licenced to import CBD products from the United States into its state of the art facility in New South Wales.
The Company is working with the New Zealand Government to establish a medical cannabis research facility and in December 2018 submitted a detailed application to the New Zealand Government to cultivate cannabis for medical research as a gateway to obtaining a cultivation licence for production.
MOCA is currently establishing a facility in New Zealand to import medical cannabis products and are seeking licences to import and distribute medical cannabis by wholesale to the New Zealand medical industry.
MOCA has several key objectives:
As a federally licenced cannabis wholesaler in Australia MOCA’s focus is on importation and exportation of high quality organic CBD and THC based products. Our expansion involves importing our specialised MOCA branded products from our partners in the United States, Canada, and Europe. Our proprietary branded products give us greater control over the overall quality of the products we import and export as well as giving the Company greater buying power, this in turn enables us to bring our organic and non-organic CBD and CBD/THC based cannabinoid products on the wholesale medical cannabis market at very competitive prices.
With an international supply chain, our state of the art warehouse and distribution facility in New South Wales enables the company to scale exponentially and operates with leading digital processes and protocols. From handling cartons of products to dozens of pallets, MOCA can handle the cannabis stock shipments and storage in our medical grade facility.
Secondly, our key area of focus is developing onsite processing and extraction of cannabis oil and production of medical grade cannabis products. Manufacturing a range of branded products including, registered therapeutic CBD and THC Oils, CBD capsules and medical vaporizers and inhalers and other medical products.
Thirdly, MOCA’s wholly owned subsidiaries in New Zealand and Italy are fully vested developing and expanding cultivation facilities, in partnership with local governments and manufacturers, our processes are seed to sale. Controlling the cultivation of our cannabis and hemp stock enables MOCA to produce the highest quality products, all produced in accordance with Good Manufacturing Practices (GMP).
The Company is enjoying significant growth in the Australian and New Zealand medicinal cannabis market. Our focus is on becoming a leading national and international producer, wholesaler and retailer of cannabis based products by expanding rapidly to meet the expected demand. We are achieving this by:
· Building our range of wholesale MOCA branded cannabis based products in Australia.
· Developing a health care client base in Australia and New Zealand through digital promotions.
· Establishing a licensed wholesale facility in New Zealand to cater to the emerging market.
· Establish a cultivation facility in New Zealand to support our branded wholesale market.
· Expand our cultivation base exponentially to cater to international demand.
· By controlling our cultivation and production process, we can support our online and offline distribution network.
We plan to grow the business through the manufacture of organic products and development of the MOCA brand over the next one to three years.
During this period, the Company will operate on a staged approach to leverage its licences and continue to bring a variety of medical cannabis products into our secure medical facility in New South Wales, including CBD and THC capsules, CBD oils and tinctures, sublinguals and concentrates. Our import licence enable us to wholesale our products to pharmacies, hospitals and licenced medical professionals. Our export licence enables the Company to sell products to licenced buyers around the world.
The Company will pursue its licence applications with New Zealand for importation, wholesale, import and to establish a cultivation facility firstly for research and secondly for cultivation of marijuana for commercial sale. The company is seeking investment for our New Zealand cannabis cultivation facility. We are establishing a wholesale distribution centre to service the local market.
Invest in the Cannabis Industry
Medicinal Organic Cannabis Australia (MOCA) is offering unique investment opportunities in Australia and New Zealand as the company scales up its production and manufacturing. As a fully licensed Australian company, MOCA is gearing up its diversity in the international landscape and seeking investment in medical cannabis. Read more about this opportunity here.
Worlds Largest Online Wholesaler of cannabis partners in Australia’s fastest growing medical cannabis company .
Medicinal Organic Cannabis Australia (MOCA) Pty Ltd is backed by the world’s largest online cannabis wholesaler, OrganicMarijuana.com, who is assisting in MOCA's expansion operations in Australia and New Zealand.
Digital Media and Marketing Strategy
Medicinal Organic Cannabis Australia (MOCA) has signed a agreement with global online leader, OrganicMarijuana.com. This partnership gives MOCA access to a powerful website platform focused on international markets.
Our focus is on organic cannabis and marijuana products and our view is on an international market, the platform has promotional and development operations that are focused in Australia orientated around Medical Organic Marijuana. OrganicMarijuana.com holds interests in cultivation facilities, manufacturing labs and produces cannabis around the world, including Organic Marijuana Israel, Jamaica, New York, Los Angeles, and Washington.
MOCA has entered into the New Zealand medical cannabis industry.
The company is seeking investment for our New Zealand cannabis cultivation facility. We are establishing a wholesale distribution centre to service the local market.
See our promo video for invest in New Zealand cannabis industry. Ground floor opportunities.